Femicef T 250mg/31.25mg Injection
Marketer
Eminent Healthcare
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Femicef T 250mg/31.25mg Injection
Cefixime and Sulbactam injection (250mg/31.25mg) is a dual-action antibiotic prescribed for diverse bacterial infections. Its mechanism combats microbial proliferation, thereby controlling infection spread. Administration must be strictly under medical guidance. Complete the prescribed dosage; premature cessation may reduce efficacy. Regular appointments are crucial. Minor side effects, such as nausea, vomiting, diarrhea, and indigestion, may occur. Severe reactions necessitate immediate medical attention. Allergic symptoms (rash, itching, swelling, breathing difficulties) require prompt medical help. Inform your doctor of all current medications, including those for pre-existing conditions, before initiating treatment. This is especially important for pregnant or breastfeeding individuals. Alcohol consumption should be avoided due to potential increased drowsiness. While typically non-impairing to driving, avoid operating vehicles if drowsiness or dizziness develops. Adequate rest, balanced nutrition, and sufficient hydration support recovery. Your physician may order tests to monitor treatment effectiveness.
Uses of Femicef T 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Femicef T 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Femicef T 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Femicef T 250mg/31.25mg Injection:
The medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Femicef T 250mg/31.25mg Injection works:
Ceftriaxone and Tazobactum, combined as Femicef T 250mg/31.25mg Injection, offer a targeted antibacterial approach. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to multiply. Tazobactum, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, thus bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
The concurrent use of alcohol and Femicef T 250mg/31.25mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Femicef T 250mg/31.25mg is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or absent negative impacts on fetal development; nevertheless, clinical data from human trials are scarce.
Breast feedingCAUTION
Administering Femicef T 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Breastfeeding should be temporarily discontinued until the mother's treatment concludes and the medication is fully cleared from her system.
DrivingUNSAFE
Administering Femicef T 250mg/31.25mg Injection could lead to drowsiness, visual impairment, or dizziness. Refrain from operating a vehicle if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Femicef T 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable medication, Femicef T 250mg/31.25mg, requires careful administration in individuals with significant hepatic impairment, potentially necessitating dosage modification. Medical consultation is advised. Dosage alteration for this injection is unnecessary in patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Femicef T 250mg/31.25mg Injection :
Should you forget a scheduled injection of Femicef T 250mg/31.25mg, seek your physician's advice.
Facts to Know About Femicef T 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently